CVE-2023-25931Medtronic Micro Clinician & InterStim X Clinician App Password Reset Issue
Updated under an hour ago ()
Does this affect you?
It affects Medtronic InsterStim Applications and 2 other products. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.27%, higher than 18% of scored CVEs.
Do this next
Free account, 1 product
Medtronic identified that the Pelvic Health clinician apps, which are installed on the Smart Programmer mobile device, have a password vulnerability that requires a security update to fix. Not updating could potentially result in unauthorized control of the clinician therapy application, which has greater control over therapy parameters than the patient app. Changes still cannot be made outside of the established therapy parameters of the programmer. For unauthorized access to occur, an individual would need physical access to the Smart Programmer.
- CVSS
- 6.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
- Weakness (CWE)
- CWE-620
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.27% (percentile 18)
- Assigned by
- Medtronic
- NVD analysis
- Modified
- Record last updated
- Mar 7, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Medtronic InsterStim Applications medtronic:insterstim_applications (from the name) | from Micro Clinician before A51200; from InterStim X Clinician before A51300 | CNA record |
medtronic interstim_x_clinician medtronic:interstim_x_clinician | a51300 | NVD |
medtronic micro_clinician medtronic:micro_clinician | a51200 | NVD |
References
- https://global.medtronic.com/xg-en/product-security/security-bulletins/pelvic-health-interstim-micro.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.